Healthtech Series B Investors & VC Firms
1027 firms in this list, with a median first check of $540K. 256 of them lead rounds. Generated from verified public data and updated continuously.
Delphinus Venture Capital
AarhusPre-Seed–Series B$108K – $1.1M
7 people
Lavni Ventures
NewarkSeed–Series B$225K – $1.7M
7 people
Moving Capital
Los AngelesSeed–Series B
7 people
NGEN Partners
New YorkSeed–Growth$5M – $20M
4 people
QC·VENTURES
ViennaSeed–Late Stage$216K – $4.3M
7 people
Seyen Capital
ChicagoSeries A–Growth
4 people
Igah Ventures
WilmingtonSeed–Series B$300K – $7.5M
9 people
JSW Ventures
MumbaiSeed–Growth
9 people
New Leaf Venture Partners
New YorkSeed–Series B
7 people
Feelsgood Capital Partners
ZagrebSeed–Growth
8 people
CLI Ventures
Palo AltoSeed–Late Stage
6 people
Lingotto
Seed–Late Stage
2 people
Montis Capital
WarsawSeries A–Growth$1.6M – $5.5M
4 people
Anjost
OxfordSeed–Growth
3 people
Kejora Capital
SingaporeSeed–Late Stage
3 people
JJDC
New BrunswickSeed–Series B$500K – $5M
11 people
Sectoral Asset Management
MontrealSeries B–Late Stage
8 people
Vertex Ventures HC
SingaporeSeed–Growth$500K – $10M
4 people
What If Ventures
FriscoPre-Seed–Late Stage
3 people
Cradle Seed Ventures
Kuala LumpurSeed–Growth$225K – $675K
3 people
Samsung Venture Investment Corporation
SeochoSeed–Series B
9 people
Vesalius Biocapital Partners
LuxembourgSeed–Growth$11M
5 people
ASICS Ventures Corporation
KobePre-Seed–Growth$100K – $5M
2 people
Banyan Ventures
New YorkPre-Seed–Series B
2 people
Related lists
Healthtech Investors & VC Firms (4190)Healthtech Seed Investors & VC Firms (3233)Series B Investors & VC Firms (2946)Healthtech Investors & VC Firms in North America (2665)Healthtech Investors & VC Firms in United States (2436)Healthtech Series A Investors & VC Firms (2309)Series B Investors & VC Firms in North America (1736)Series B Investors & VC Firms in United States (1571)Healthtech Pre-Seed Investors & VC Firms (1468)Healthtech Investors & VC Firms in Europe (1357)
Data sourced from public filings and firms' own websites — see our methodology.




































































